newsfilter
← Latest News
GlobeNewswire·

SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

JERSEY CITY, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ:SCYX), a clinical-stage biotechnology company focused on developing innovative therapies for severe and difficult-to-treat diseases with